{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:00:19Z","timestamp":1791525619239,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Ulm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>p190A has been studied across various cancer types, and mutation rates of up to 20% were observed in some cancers, supporting the significance of p190A in carcinogenesis. Since the relevance of p190A in bladder cancer has not been addressed so far, we attempted to explore it. Evaluation of TCGA high-throughput sequencing datasets revealed p190A mutations in up to 8% of bladder cancer samples across several studies. Employing immunohistochemistry on tissue microarray that included 202 BC patient samples, we observed that lower p190A expression correlates with increased invasiveness and poorer survival outcomes. These findings suggested that p190A may have a tumor suppressor function in bladder tissue, consistent with its anticipated function in ploidy-control. p190A knockdown resulted in chromosomal instability in ureter-derived epithelial cells with otherwise normal karyotype, supporting its potential involvement in tumorigenesis. Loss-of-function studies in low-invasive bladder RT4 cell line and gain-of-function experiments in two highly invasive bladder cancer cell lines (T24 and BFTC) demonstrated that p190A influences cell migration and invasion in vitro, as determined by scratch assay and Boyden chamber approaches. This conclusion was further validated by ex vivo porcine bladder invasion approach, invadopodia formation, and gelatin degradation assays. Pathway analysis revealed that altered p190A expression influences both the Rho-ROCK-dependent LIMK1-cofilin pathway and the phosphorylation of cortactin by focal adhesion kinase, both of which regulate critical cellular processes such as actin network organization and polarization to facilitate efficient, coordinated cell migration and division. In summary, our results indicate that p190A has a genuine role in controlling cell-ploidy and regulates actin dynamics in the bladder urothelium, while loss of p190A results in genome instability and drives bladder cancer initiation and progression through deregulated actin dynamics.<\/jats:p>","DOI":"10.1038\/s41598-025-23687-4","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:40:34Z","timestamp":1763466034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Loss of p190A RhoGAP induces aneuploidy and enhances bladder cancer cell migration and invasion by modulating actin dynamics"],"prefix":"10.1038","volume":"15","author":[{"given":"Qianyu","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregoire","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Azoitei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Zengerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Wezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bolenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagatay","family":"G\u00fcnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"23687_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/cm.20472","volume":"67","author":"M Amano","year":"2010","unstructured":"Amano, M., Nakayama, M. & Kaibuchi, K. Rho-kinase\/ROCK: A key regulator of the cytoskeleton and cell Polarity. Cytoskeleton (Hoboken N J). 67, 545\u2013554. https:\/\/doi.org\/10.1002\/cm.20472 (2010).","journal-title":"Cytoskeleton (Hoboken N J)"},{"key":"23687_CR2","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.3892\/ol.2019.10515","volume":"18","author":"J Bai","year":"2019","unstructured":"Bai, J., Xu, J., Zhao, J. & Zhang, R. Downregulation of LncRNA AWPPH inhibits colon cancer cell proliferation by downregulating GLUT-1. Oncol. Lett. 18, 2007\u20132012. https:\/\/doi.org\/10.3892\/ol.2019.10515 (2019).","journal-title":"Oncol. Lett."},{"key":"23687_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ejcb.2008.02.008","volume":"87","author":"B Blouw","year":"2008","unstructured":"Blouw, B., Seals, D. F., Pass, I., Diaz, B. & Courtneidge, S. A. A role for the podosome\/invadopodia scaffold protein Tks5 in tumor growth in vivo. Eur. J. Cell Biol. 87, 555\u2013567. https:\/\/doi.org\/10.1016\/j.ejcb.2008.02.008 (2008).","journal-title":"Eur. J. Cell Biol."},{"key":"23687_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1128\/mcb.11.2.945-953.1991","volume":"11","author":"AH Bouton","year":"1991","unstructured":"Bouton, A. H. et al. Transformation by pp60src or stimulation of cells with epidermal growth factor induces the stable association of tyrosine-phosphorylated cellular proteins with GTPase-activating protein. Mol. Cell. Biol. 11, 945\u2013953. https:\/\/doi.org\/10.1128\/mcb.11.2.945-953.1991 (1991).","journal-title":"Mol. Cell. Biol."},{"issue":"Suppl 1","key":"23687_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/jcs.025742","volume":"121","author":"T Boveri","year":"2008","unstructured":"Boveri, T. Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J. Cell Sci. 121 (Suppl 1), 1\u201384. https:\/\/doi.org\/10.1242\/jcs.025742 (2008).","journal-title":"J. Cell Sci."},{"key":"23687_CR6","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cub.2005.06.043","volume":"15","author":"NS Bryce","year":"2005","unstructured":"Bryce, N. S. et al. Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr. Biology: CB. 15, 1276\u20131285. https:\/\/doi.org\/10.1016\/j.cub.2005.06.043 (2005).","journal-title":"Curr. Biology: CB"},{"key":"23687_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbcan.2006.12.002","volume":"1775","author":"L Buday","year":"2007","unstructured":"Buday, L. & Downward, J. Roles of cortactin in tumor pathogenesis. Biochim. Biophys. Acta. 1775, 263\u2013273. https:\/\/doi.org\/10.1016\/j.bbcan.2006.12.002 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"23687_CR8","first-page":"781","volume":"17","author":"D Pantazopoulos","year":"1997","unstructured":"Pantazopoulos, D. et al. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder. Anticancer Res. 17, 781\u2013786 (1997).","journal-title":"Anticancer Res."},{"key":"23687_CR9","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/ng.2760","volume":"45","author":"TI Zack","year":"2013","unstructured":"Zack, T. I. et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45, 1134\u20131140. https:\/\/doi.org\/10.1038\/ng.2760 (2013).","journal-title":"Nat. Genet."},{"key":"23687_CR10","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor, A. M. et al. Genomic and functional approaches to Understanding cancer aneuploidy. Cancer cell. 33, 676\u2013689. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.007 (2018).","journal-title":"Cancer cell."},{"key":"23687_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrg3123","volume":"13","author":"DJ Gordon","year":"2012","unstructured":"Gordon, D. J., Resio, B. & Pellman, D. Causes and consequences of aneuploidy in cancer. Nat. Rev. Genet. 13, 189\u2013203. https:\/\/doi.org\/10.1038\/nrg3123 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"23687_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00204-008-0280-3","volume":"82","author":"AR Florl","year":"2008","unstructured":"Florl, A. R. & Schulz, W. A. Chromosomal instability in bladder cancer. Arch. Toxicol. 82, 173\u2013182. https:\/\/doi.org\/10.1007\/s00204-008-0280-3 (2008).","journal-title":"Arch. Toxicol."},{"key":"23687_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00240-004-0439-1","volume":"33","author":"C Deliveliotis","year":"2005","unstructured":"Deliveliotis, C. et al. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder. Urol. Res. 33, 39\u201343. https:\/\/doi.org\/10.1007\/s00240-004-0439-1 (2005).","journal-title":"Urol. Res."},{"key":"23687_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.cellbio.21.020604.150721","volume":"21","author":"AB Jaffe","year":"2005","unstructured":"Jaffe, A. B. & Hall, A. Rho gtpases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21, 247\u2013269. https:\/\/doi.org\/10.1146\/annurev.cellbio.21.020604.150721 (2005).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"23687_CR15","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1042\/bst20120103","volume":"40","author":"A Hall","year":"2012","unstructured":"Hall, A. Rho family GTPases. Biochem. Soc. Trans. 40, 1378\u20131382. https:\/\/doi.org\/10.1042\/bst20120103 (2012).","journal-title":"Biochem. Soc. Trans."},{"key":"23687_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/21541248.2016.1232583","volume":"7","author":"RB Haga","year":"2016","unstructured":"Haga, R. B. & Ridley, A. J. Rho gtpases: regulation and roles in cancer cell biology. Small GTPases. 7, 207\u2013221. https:\/\/doi.org\/10.1080\/21541248.2016.1232583 (2016).","journal-title":"Small GTPases"},{"key":"23687_CR17","doi-asserted-by":"publisher","unstructured":"H\u00e9raud, C., Pinault, M., Lagr\u00e9e, V. & Moreau, V. p190RhoGAPs, the ARHGAP35- and ARHGAP5-Encoded Proteins, in health and disease. Cells 8, 2563.  https:\/\/doi.org\/10.3390\/cells8040351 (2019).","DOI":"10.3390\/cells8040351"},{"key":"23687_CR18","doi-asserted-by":"publisher","first-page":"657219","DOI":"10.3389\/fcell.2021.657219","volume":"9","author":"C Yang","year":"2021","unstructured":"Yang, C. et al. Transcriptomic analysis identified ARHGAP family as a novel biomarker associated with Tumor-Promoting immune infiltration and Nanomechanical characteristics in bladder cancer. Front. Cell. Dev. Biol. 9, 657219. https:\/\/doi.org\/10.3389\/fcell.2021.657219 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"23687_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1242\/jcs.151647","volume":"128","author":"A Manukyan","year":"2015","unstructured":"Manukyan, A., Ludwig, K., Sanchez-Manchinelly, S., Parsons, S. J. & Stukenberg, P. T. A complex of p190RhoGAP-A and anillin modulates RhoA-GTP and the cytokinetic furrow in human cells. J. Cell Sci. 128, 50\u201360. https:\/\/doi.org\/10.1242\/jcs.151647 (2015).","journal-title":"J. Cell Sci."},{"key":"23687_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1083\/jcb.200308007","volume":"163","author":"L Su","year":"2003","unstructured":"Su, L., Agati, J. M. & Parsons, S. J. p190RhoGAP is cell cycle regulated and affects cytokinesis. J. Cell Biol. 163, 571\u2013582. https:\/\/doi.org\/10.1083\/jcb.200308007 (2003).","journal-title":"J. Cell Biol."},{"key":"23687_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00412-018-0670-0","volume":"127","author":"A Manukyan","year":"2018","unstructured":"Manukyan, A., Sargsyan, L., Parsons, S. J. & Stukenberg, P. T. P190RhoGAP prevents mitotic spindle fragmentation and is required to activate Aurora A kinase at acentriolar Poles. Chromosoma 127, 375\u2013386. https:\/\/doi.org\/10.1007\/s00412-018-0670-0 (2018).","journal-title":"Chromosoma"},{"key":"23687_CR22","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.1158\/0008-5472.Can-08-0997","volume":"68","author":"CH Shen","year":"2008","unstructured":"Shen, C. H. et al. Breast tumor kinase phosphorylates p190RhoGAP to regulate Rho and Ras and promote breast carcinoma growth, migration, and invasion. Cancer Res. 68, 7779\u20137787. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-0997 (2008).","journal-title":"Cancer Res."},{"key":"23687_CR23","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.3892\/ijo.2013.2096","volume":"43","author":"H Notsuda","year":"2013","unstructured":"Notsuda, H. et al. p190A RhoGAP is involved in EGFR pathways and promotes proliferation, invasion and migration in lung adenocarcinoma cells. Int. J. Oncol. 43, 1569\u20131577. https:\/\/doi.org\/10.3892\/ijo.2013.2096 (2013).","journal-title":"Int. J. Oncol."},{"key":"23687_CR24","doi-asserted-by":"publisher","first-page":"15147","DOI":"10.1074\/jbc.M807834200","volume":"284","author":"I Molina-Ortiz","year":"2009","unstructured":"Molina-Ortiz, I., Bartolom\u00e9, R. A., Hern\u00e1ndez-Varas, P., Colo, G. P. & Teixid\u00f3, J. Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP\/p120ctn-dependent inactivation of RhoA. J. Biol. Chem. 284, 15147\u201315157. https:\/\/doi.org\/10.1074\/jbc.M807834200 (2009).","journal-title":"J. Biol. Chem."},{"key":"23687_CR25","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1349-7006.2006.00242.x","volume":"97","author":"T Kusama","year":"2006","unstructured":"Kusama, T. et al. Inactivation of Rho GTPases by p190 RhoGAP reduces human pancreatic cancer cell invasion and metastasis. Cancer Sci. 97, 848\u2013853. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00242.x (2006).","journal-title":"Cancer Sci."},{"key":"23687_CR26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1083\/jcb.201601063","volume":"214","author":"F Binam\u00e9","year":"2016","unstructured":"Binam\u00e9, F. et al. Cancer-associated mutations in the protrusion-targeting region of p190RhoGAP impact tumor cell migration. J. Cell Biol. 214, 859\u2013873. https:\/\/doi.org\/10.1083\/jcb.201601063 (2016).","journal-title":"J. Cell Biol."},{"key":"23687_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41417-022-00547-1","volume":"30","author":"H Yagi","year":"2023","unstructured":"Yagi, H. et al. Tumor-derived ARHGAP35 mutations enhance the Galpha(13)-Rho signaling axis in human endometrial cancer. Cancer Gene Ther. 30, 313\u2013323. https:\/\/doi.org\/10.1038\/s41417-022-00547-1 (2023).","journal-title":"Cancer Gene Ther."},{"key":"23687_CR28","doi-asserted-by":"publisher","first-page":"11790","DOI":"10.1038\/s41598-024-62577-z","volume":"14","author":"H Fei","year":"2024","unstructured":"Fei, H. et al. Integrated analysis identified the role of three family members of ARHGAP in pancreatic adenocarcinoma. Sci. Rep. 14, 11790. https:\/\/doi.org\/10.1038\/s41598-024-62577-z (2024).","journal-title":"Sci. Rep."},{"key":"23687_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12253-017-0208-4","volume":"24","author":"EJ Choi","year":"2018","unstructured":"Choi, E. J., Kim, M. S., Song, S. Y., Yoo, N. J. & Lee, S. H. Low frequent mutation of ARHGAP35, a candidate tumor suppressor Gene, in gastric and colorectal cancers. Pathol. Oncol. Res. 24, 175\u2013176. https:\/\/doi.org\/10.1007\/s12253-017-0208-4 (2018).","journal-title":"Pathol. Oncol. Res."},{"key":"23687_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s11658-024-00609-2","volume":"29","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Impairment of alpha-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasion. Cell. Mol. Biol. Lett. 29, 94. https:\/\/doi.org\/10.1186\/s11658-024-00609-2 (2024).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"23687_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00018-023-04959-6","volume":"80","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Loss of ORP3 induces aneuploidy and promotes bladder cancer cell invasion through deregulated microtubule and actin dynamics. Cell. Mol. Life Sci. 80, 299. https:\/\/doi.org\/10.1007\/s00018-023-04959-6 (2023).","journal-title":"Cell. Mol. Life Sci."},{"key":"23687_CR32","doi-asserted-by":"publisher","unstructured":"Wang, W. et al. The role of TKS5 in chromosome stability and bladder cancer progression. Int. J. Mol. Sci. 23, 7452.  https:\/\/doi.org\/10.3390\/ijms232214283 (2022).","DOI":"10.3390\/ijms232214283"},{"key":"23687_CR33","doi-asserted-by":"publisher","unstructured":"Wezel, F. et al. Grainyhead-Like 3 influences migration and invasion of urothelial carcinoma cells. Int. J. Mol. Sci. 22, 985.  https:\/\/doi.org\/10.3390\/ijms22062959 (2021).","DOI":"10.3390\/ijms22062959"},{"key":"23687_CR34","doi-asserted-by":"publisher","unstructured":"D\u00edaz, B. Invadopodia detection and gelatin degradation assay. Bio-protocol 3, 963.  https:\/\/doi.org\/10.21769\/BioProtoc.997 (2013).","DOI":"10.21769\/BioProtoc.997"},{"key":"23687_CR35","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1126\/science.285.5429.895","volume":"285","author":"M Maekawa","year":"1999","unstructured":"Maekawa, M. et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285, 895\u2013898. https:\/\/doi.org\/10.1126\/science.285.5429.895 (1999).","journal-title":"Science"},{"key":"23687_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev.cellbio.15.1.185","volume":"15","author":"JR Bamburg","year":"1999","unstructured":"Bamburg, J. R. Proteins of the ADF\/cofilin family: essential regulators of actin dynamics. Annu. Rev. Cell Dev. Biol. 15, 185\u2013230. https:\/\/doi.org\/10.1146\/annurev.cellbio.15.1.185 (1999).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"23687_CR37","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1093\/cercor\/bhw122","volume":"27","author":"C Iobbi","year":"2017","unstructured":"Iobbi, C., Korte, M. & Zagrebelsky, M. Nogo-66 restricts synaptic strengthening via Lingo1 and the ROCK2-Cofilin pathway to control actin dynamics. Cereb. Cortex (New York N Y : 1991). 27, 2779\u20132792. https:\/\/doi.org\/10.1093\/cercor\/bhw122 (2017).","journal-title":"Cereb. Cortex (New York N Y : 1991)"},{"key":"23687_CR38","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.3390\/ijms16024095","volume":"16","author":"CY Chang","year":"2015","unstructured":"Chang, C. Y., Leu, J. D. & Lee, Y. J. The actin depolymerizing factor (ADF)\/cofilin signaling pathway and DNA damage responses in cancer. Int. J. Mol. Sci. 16, 4095\u20134120. https:\/\/doi.org\/10.3390\/ijms16024095 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"23687_CR39","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/med.20230","volume":"32","author":"F Manetti","year":"2012","unstructured":"Manetti, F. LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators. Med. Res. Rev. 32, 968\u2013998. https:\/\/doi.org\/10.1002\/med.20230 (2012).","journal-title":"Med. Res. Rev."},{"key":"23687_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-018-0825-x","volume":"17","author":"Y Tang","year":"2018","unstructured":"Tang, Y. et al. LncRNAs regulate the cytoskeleton and related Rho\/ROCK signaling in cancer metastasis. Mol. Cancer. 17, 77. https:\/\/doi.org\/10.1186\/s12943-018-0825-x (2018).","journal-title":"Mol. Cancer"},{"key":"23687_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/cm.20328","volume":"66","author":"A Shvetsov","year":"2009","unstructured":"Shvetsov, A., Berkane, E., Chereau, D., Dominguez, R. & Reisler, E. The actin-binding domain of cortactin is dynamic and unstructured and affects lateral and longitudinal contacts in F-actin. Cell Motil. Cytoskeleton. 66, 90\u201398. https:\/\/doi.org\/10.1002\/cm.20328 (2009).","journal-title":"Cell Motil. Cytoskeleton"},{"key":"23687_CR42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jez.1402510206","volume":"251","author":"WT Chen","year":"1989","unstructured":"Chen, W. T. Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J. Exp. Zool. 251, 167\u2013185. https:\/\/doi.org\/10.1002\/jez.1402510206 (1989).","journal-title":"J. Exp. Zool."},{"key":"23687_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1074\/jbc.273.1.9","volume":"273","author":"H Nakahara","year":"1998","unstructured":"Nakahara, H. et al. Activation of beta1 integrin signaling stimulates tyrosine phosphorylation of p190RhoGAP and membrane-protrusive activities at invadopodia. J. Biol. Chem. 273, 9\u201312. https:\/\/doi.org\/10.1074\/jbc.273.1.9 (1998).","journal-title":"J. Biol. Chem."},{"key":"23687_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s0092-8674(00)81280-5","volume":"84","author":"DA Lauffenburger","year":"1996","unstructured":"Lauffenburger, D. A. & Horwitz, A. F. Cell migration: a physically integrated molecular process. Cell 84, 359\u2013369. https:\/\/doi.org\/10.1016\/s0092-8674(00)81280-5 (1996).","journal-title":"Cell"},{"key":"23687_CR45","doi-asserted-by":"publisher","unstructured":"Jiang, W. G. et al. Tissue invasion and metastasis: Molecular, biological and clinical perspectives. Sem. Cancer Biol. 35, 2563. https:\/\/doi.org\/10.1016\/j.semcancer.2015.03.008 (2015).","DOI":"10.1016\/j.semcancer.2015.03.008"},{"key":"23687_CR46","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/path.3018","volume":"226","author":"T Lechertier","year":"2012","unstructured":"Lechertier, T. & Hodivala-Dilke, K. Focal adhesion kinase and tumour angiogenesis. J. Pathol. 226, 404\u2013412. https:\/\/doi.org\/10.1002\/path.3018 (2012).","journal-title":"J. Pathol."},{"key":"23687_CR47","doi-asserted-by":"publisher","first-page":"e44041","DOI":"10.1371\/journal.pone.0044041","volume":"7","author":"A Tomar","year":"2012","unstructured":"Tomar, A., Lawson, C., Ghassemian, M. & Schlaepfer, D. D. Cortactin as a target for FAK in the regulation of focal adhesion dynamics. PLoS One. 7, e44041. https:\/\/doi.org\/10.1371\/journal.pone.0044041 (2012).","journal-title":"PLoS One"},{"key":"23687_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1083\/jcb.200807195","volume":"185","author":"F Sabeh","year":"2009","unstructured":"Sabeh, F., Shimizu-Hirota, R. & Weiss, S. J. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J. Cell Biol. 185, 11\u201319. https:\/\/doi.org\/10.1083\/jcb.200807195 (2009).","journal-title":"J. Cell Biol."},{"key":"23687_CR49","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1083\/jcb.200209006","volume":"160","author":"K Wolf","year":"2003","unstructured":"Wolf, K. et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160, 267\u2013277. https:\/\/doi.org\/10.1083\/jcb.200209006 (2003).","journal-title":"J. Cell Biol."},{"key":"23687_CR50","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1182\/blood-2012-03-419663","volume":"120","author":"DA Moulding","year":"2012","unstructured":"Moulding, D. A. et al. Excess F-actin mechanically impedes mitosis leading to cytokinesis failure in X-linked neutropenia by exceeding Aurora B kinase error correction capacity. Blood 120, 3803\u20133811. https:\/\/doi.org\/10.1182\/blood-2012-03-419663 (2012).","journal-title":"Blood"},{"key":"23687_CR51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1084\/jem.20091245","volume":"207","author":"LS Westerberg","year":"2010","unstructured":"Westerberg, L. S. et al. Activating WASP mutations associated with X-linked neutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes. J. Exp. Med. 207, 1145\u20131152. https:\/\/doi.org\/10.1084\/jem.20091245 (2010).","journal-title":"J. Exp. Med."},{"key":"23687_CR52","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1083\/jcb.201710058","volume":"217","author":"SR Frank","year":"2018","unstructured":"Frank, S. R. et al. p190 RhoGAP promotes contact Inhibition in epithelial cells by repressing YAP activity. J. Cell Biol. 217, 3183\u20133201. https:\/\/doi.org\/10.1083\/jcb.201710058 (2018).","journal-title":"J. Cell Biol."},{"key":"23687_CR53","doi-asserted-by":"publisher","unstructured":"Ouyang, H., Li, W. & Hansen, S. H. p120 RasGAP and ZO-2 are essential for Hippo signaling and tumor suppressor function mediated by p190A RhoGAP. bioRxiv.  https:\/\/doi.org\/10.1101\/2023.05.22.541483  (2023).","DOI":"10.1101\/2023.05.22.541483"},{"key":"23687_CR54","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1038\/s41388-020-1385-2","volume":"39","author":"H Ouyang","year":"2020","unstructured":"Ouyang, H., Luong, P., Frodin, M. & Hansen, S. H. p190A RhoGAP induces CDH1 expression and cooperates with E-cadherin to activate LATS kinases and suppress tumor cell growth. Oncogene 39, 5570\u20135587. https:\/\/doi.org\/10.1038\/s41388-020-1385-2 (2020).","journal-title":"Oncogene"},{"key":"23687_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41392-020-0170-6","volume":"5","author":"X Wen","year":"2020","unstructured":"Wen, X. et al. p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer. Signal. Transduct. Target. Ther. 5, 81. https:\/\/doi.org\/10.1038\/s41392-020-0170-6 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"23687_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"UALCAN","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar, D. S. et al. An update to the integrated cancer data analysis platform. Neoplasia 25. UALCAN, 18\u201327. https:\/\/doi.org\/10.1016\/j.neo.2022.01.001 (2022).","journal-title":"Neoplasia 25"},{"key":"23687_CR57","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar, D. S. et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19, 649\u2013658. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002 (2017).","journal-title":"Neoplasia"},{"key":"23687_CR58","doi-asserted-by":"publisher","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088 (2013).","DOI":"10.1126\/scisignal.2004088"},{"key":"23687_CR59","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095 (2012).","journal-title":"Cancer Discov"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23687-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23687-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23687-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:02:46Z","timestamp":1763856166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23687-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23687"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23687-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6362761\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments. All patients agreed and gave informed consent, and all analyzes. Ethical approval for the immunohistochemistry experiments on human tissue samples was obtained by the ethical review board of the Friedrich-Alexander-University Erlangen-N\u00fcrnberg (Erlangen, Germany; approval number: no. 3755 and 329_16B).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"40399"}}